Induction of humoral immunity in response to immunization with recombinant Mycobacterium bovis BCG expressing the S1 subunit of Bordetella pertussis toxin

Canadian Journal of Microbiology

Volumn 51, Issue 12, 2005, Pages 1015-1020

  Medeiros, Marco A ^a   Armôa, Geraldo R G ^a   Dellagostin, Odir A ^b   McIntosh, Douglas ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

B. pertussis; Humoral immune response; Recombinant BCG

Indexed keywords

COST EFFECTIVENESS; DATA ACQUISITION;

B. PERTUSSIS; HUMORAL IMMUNE RESPONSE; RECOMBINANT BCG;

VACCINES;

IMMUNOGLOBULIN G; PERTUSSIS TOXIN; PERTUSSIS VACCINE; PROTEIN SUBUNIT; RECOMBINANT VACCINE;

IMMUNE RESPONSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL STRAIN; BORDETELLA PERTUSSIS; CONTROLLED STUDY; DRUG SYNTHESIS; FEMALE; HSP60 GENE; HUMORAL IMMUNITY; IMMUNIZATION; IN VITRO STUDY; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM PARATUBERCULOSIS; NONHUMAN; PAN GENE; PERTUSSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROVOCATION TEST;

ANIMALS; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; DRUG EVALUATION, PRECLINICAL; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED BALB C; MYCOBACTERIUM BOVIS; MYCOBACTERIUM PARATUBERCULOSIS; PERTUSSIS TOXIN; PERTUSSIS VACCINE; PROMOTER REGIONS (GENETICS); RECOMBINANT PROTEINS; VACCINES, SYNTHETIC; WHOOPING COUGH;

ANIMALIA; BACTERIA (MICROORGANISMS); BORDETELLA PERTUSSIS; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG;

EID: 33644848136     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/w05-095     Document Type: Article

References (27)

1. Abomoelak, B., Huygen, K., Kremer, L., Turnee, M., and Locht, C. 1999. Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guérin producing a pertussis toxin - tetanus toxin hybrid protein. Infect. Immun. 67: 5100-5105.
2. Al-Zarouni, M., and Dale, J.W. 2002. Expression of foreign genes in Mycobacterium bovis BCG strains using different promoters reveals instability of the hsp60 promoter for expression of foreign genes in Mycobacterium bovis BCG strains. Tuberculosis, 82: 283-291.
3. Blumberg, D.A., Lewis, K., Mink, C.M., Christenson, P.D., Chatifield, P., and Cherry, J.D. 1993. Severe reactions associated with diphtheria-tetanus- pertussis vaccine: detailed study of children with seizures, hypotonic-hyporesponsive episodes, high fevers, and persistent crying. Pediatrics, 91: 1158-1165.
4. Boucher, P., Sato, H., Sato, Y., and Locht, C. 1994. Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin - tetanus toxin fusion protein. Infect. Immun. 62: 449-456.
5. Canthaboo, C., Willians, L., Xing, D.K.L., and Corbel, M.J. 2001. Investigation of cellular and humoral immune response to whole cell and acellular pertussis vaccines. Vaccine, 19: 637-643.
6. Cassone, A., Ausiello, C.M., Urbani, F., Lande, R., Giuliano, M., La Sala, A., Piscitelli, A., and Salmaso, S. 1997. Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group. Arch. Pediatr. Adolesc. Med. 151: 283-289.
7. da Cruz, F.W., McBride, A.J.A., Conceição, F.R., Dale, J.W., McFadden, J., and Dellagostin, O.A. 2002. Expression of the B-cell and T-cell epitopes of the rabies virus nucleoprotein in Mycobacterium bovis BCG and induction of an humoral response in mice. Vaccine, 20: 731-736.
8. Di Tommaso, A., Bartalini, M., Peppoloni, S., Podda, A., Rappuoli, R., and De Margistris, M.T. 1997. Acellular pertussis vaccines containing genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults. Vaccine, 15: 1218-1224.
9. Edelman, R., Palmer, K., Russ, K.G., Secrest, H.P., Becker, J.A., Bodison, S.A., Perry, J.G., Sills, A.R., Barbour, A.G., Luke, C.J., Hanson, M.S., Stover, C.K., Burlein, J.E., Bansal, G.P., Connor, E.M., and Koenig, S. 1999. Safety and immunogenicity of recombinant Bacille Calmette-Guerin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine. Vaccine, 17: 904-914.
10. Grode, L., Kursar, M., Fensterle, J., Kaufmann, S.H., and Hess, J. 2002. Cell-mediated immunity induced by recombinant Mycobacterium bovis Bacille Calmette-Guérin strains against an intracellular bacterial pathogen: importance of antigen secretion or membrane-targeted antigen display as lipoprotein for vaccine efficacy. J. Immunol. 168: 1869-1876.
11. Haeseleer, F. 1994. Structural instability of recombinant plasmids in mycobacteria. Res. Microbiol. 145: 683-687.
12. Hanson, M.S., Lapcevich, C.V., and Haun, S.L. 1995. Progress on development of the live BCG recombinant vaccine vehicle for combined vaccine delivery. Ann. N.Y. Acad. Sci. 754: 214-221.
13. Lagranderie, M., Lo-Man, R., Dȩriaud, E., Gicquel, B., Gheorghiu, M., and Leclerc, C. 1997. Genetic control of antibody response induced by recombinant Mycobacterium bovis BCG expressing a foreign antigen. Infect. Immun. 65: 3057-3064.
14. Langermann, S., Palaszynski, S.R., Burlein, J.E., Koenig, S., Hanson, M.S., Briles, D.E., and Stover, C.K. 1994. protective humoral response against pneumococcal infection in mice elicited by recombinant Bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A. J. Exp. Med. 180: 2277-2286.
15. Leung, N.J., Aldovini, A., Young, R., Jarvis, M.A., Smith, J.M., Meyer, D., Anderson, D.E., Carlos, M.P., Gardener, M.B., and Torres, J.V. 2000. The kinetics of specific immune response in rhesus monkeys inoculated with live recombinant BCG expressing SIV gag, pol, env, and nef proteins. Virology, 268: 94-103.
16. Medeiros, M., Dellagostin, O.A., Armoa, G.R.G., Degrave, W.M., Mendonça-Lima, L., Lopes, M.Q., Costa, J.F., McFadden, J.G.M.B., and McIntosh, D. 2002. Comparative evaluation of Mycobacterium vaccae as a surrogate cloning host for use in the study of mycobacterial genetics. Microbiology (Reading, U.K.), 148: 1999-2009.
17. Méderlé, I., Bourguin, I., Ensergueix, D., Badell, E., Moniz-Peireira, J., Gicquel, B., and Winter, N. 2002. Plasmidic versus insertional cloning of heterologous genes in Mycobacterium bovis BCG: impact on in vivo antigen persistence and immune responses. Infect. Immun. 70: 303-314.
18. Mills, K.H.G., Ryan, M., McGuirk, P., Griffin, F., Murphy, G., and Mahon, B. 1999. The immunology of Bordetella pertussis infection. Biologicals, 27: 77.
19. Nascimento, I.P., Dias, W.O., Mazzantini, R.P., Miyagi, E.N., Gamberini, M., Quintilio, W., Gebara, V.C., Cardoso, D.F., Ho, P.L., Raw, I., Winter, N., Gicquel, B., Rappuoli, R., and Leite, L. 2000. Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice. Infect. Immun. 68: 4877-4883.
20. Ohara, N., and Yamada, T. 2001. Recombinant BCG vaccines. Vaccine, 19: 4089-4098.
21. Ryan, M., Murphy, G., Ryan, E., Nilsson, L., Shackley, F., Gothefors, L., Oymar, K., Miller, E., Storsaeter, J., and Mills, K.H. 1998. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology, 193: 1-10.
22. Sato, H., Sato, Y., and Ohishi, I. 1991. Comparison of pertussis toxin (PT)-neutralizing activities and mouse-protective activities of anti-PT mouse monoclonal antibodies. Infect. Immun. 59: 3832-3835.
23. Sato, Y., and Sato, H. 1999. Development of acellular pertussis vaccines. Biologicals, 27: 61-69.
24. Stover, C.K., Bansal, G.P., Hanson, M.S., Burlein, J.E., Palaszynski, S.R., Young, J.F., Koenig, S., Young, D.B., Sadziene, A., and Barbour, A.G. 1993. Protective immunity elicited by recombinant Bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J. Exp. Med. 178: 197-209.
25. Stover, C.K., Bansal, G.P., Langermann, S., and Hanson, M.S. 1994. Protective immunity elicited by rBCG vaccines. Dev. Biol. Stand. 82: 163-70.
26. Trollfors, B., Taranger, J., Lagergard, T., Lind, L., Sundh, V., Zackrisson, G., Lowe, C.U., Blackwelder, W., and Robbins, J.B. 1995. A placebo-controlled trial of a pertussis-toxoid vaccine. New Engl. J. Med. 333: 1045-1050.
27. Van Den Berg, B.M., David, S., Beekhuizen, H., Mooi, F.R., and Van Furth, R. 2001. Protection and humoral immune response against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens. Vaccine, 19: 1018-1128.